跳至主要内容
临床试验/ITMCTR1900002629
ITMCTR1900002629尚未招募2 期

Evaluation and optimization of TCM comprehensive treatment plan in acute stage of cerebral hemorrhage

Chengdu University of Traditional Chinese Medicine Clinical Medical College0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 80(—)
性别
All

入选标准

  • 1. Aged 40 to 80 years;
  • 2. Meet the diagnostic criteria for acute hemorrhagic stroke;
  • 3. Acute cerebral hemorrhage onset time is less than 1 week;
  • 4. NIHSS score >= 6 points;
  • 5. Family or I sign a written informed consent form for participation in this trial.
  • Who meet the above 5 items at the same time can be included in the study.

排除标准

  • 1. It has been confirmed by examination that cerebral hemorrhage is caused by brain tumor, brain trauma, blood disease (secondary to anticoagulant and thrombolytic therapy), vascular malformation or cerebral aneurysm;
  • 2. Surgical treatment of patients;
  • 3. Pregnant, lactating women;
  • 4. Onset is accompanied by severe heart disease, liver dysfunction, renal insufficiency, respiratory failure, malignant tumors, gastrointestinal bleeding, etc.;
  • 5. Psychiatric patients;
  • 6. Participating in other clinical trials.

研究者

发起方
Chengdu University of Traditional Chinese Medicine Clinical Medical College

相似试验